Nektar Therapeutics | D: Filing D
Nektar Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-TCG Crossover GP II, LLC(9.9%),TCG Crossover Fund II, L.P.(9.9%), etc.
Nektar Therapeutics | 3: Initial statement of beneficial ownership of securities-10% Owner Deep Track Capital, LP
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Zalevsky Jonathan
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Wilson Mark Andrew
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer ROBIN HOWARD W
Nektar Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(0%),Peter Kolchinsky(0%), etc.
Nektar Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Citadel Advisors LLC(3.0%),Citadel Advisors Holdings LP(3.0%), etc.
Nektar Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deep Track Capital, LP(9.65%),Deep Track Biotechnology Master Fund, Ltd.(9.65%), etc.
Nektar Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(6.31%)
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Zalevsky Jonathan
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Legal Officer Wilson Mark Andrew
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer ROBIN HOWARD W
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Zalevsky Jonathan
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Legal Officer Wilson Mark Andrew
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer ROBIN HOWARD W
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director GREER R SCOTT
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WHITFIELD ROY A
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Curet Myriam
Nektar Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director CHESS ROBERT
No Data